Securities Code: 002390 Securities Abbreviation: Xinbang Pharmaceutical Announcement No.: 2026-018 Guizhou Xinbang Pharmaceutical Co., Ltd. Announcement on Providing Guarantees for Subsidiaries The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there is no false record, misleading statement, or significant omission.
I. Approval of Guarantee Matters
Guizhou Xinbang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") considered and approved the "Proposal on Applying for Credit Facilities and Guarantees in 2026" at the tenth meeting of the ninth Board of Directors held on April 17, 2026. The Board of Directors agreed that the Company and its subsidiaries within the consolidated financial statements (hereinafter referred to as "subsidiaries") will apply for comprehensive credit facilities from banks totaling no more than RMB 1.8 billion in 2026. The Company will provide guarantees for subsidiaries up to RMB 150,000 million, of which the guarantee amount for subsidiaries with a debt-to-asset ratio below 70% shall not exceed RMB 100,000 million, and the guarantee amount for subsidiaries with a debt-to-asset ratio of 70% or above shall not exceed RMB 50,000 million. For details, please refer to the "Announcement on the Company's Application for Credit Facilities and Guarantees in 2026" (Announcement No.: 2026-009) published in China Securities Journal, Securities Times, and CNINFO.COM.CN (http://www.cninfo.com.cn) on April 21, 2026. The above matter was deliberated and approved by the Company's 2025 Annual Shareholders' Meeting on May 12, 2026.
II. Matters Regarding the Company Providing Guarantees for Guizhou Xinbang Pharmaceutical Co., Ltd. (hereinafter referred to as "Xinbang Pharmaceutical")
- Guarantee Overview
On June 18, 2026, the Company and China Everbright Bank Co., Ltd. Guiyang Branch re-signed the "Maximum Amount Guarantee Contract" (No.: Guiyingbu Zongshou Bao 2026017) in Guiyang City. The Company will provide guarantees for the comprehensive credit facilities applied for by its wholly-owned subsidiary, Xinbang Pharmaceutical, from China Everbright Bank Co., Ltd., with a guarantee amount of RMB 50 million.
- Basic Information of the Guaranteed Party